Ancillary Study to Protocol 20060104

NCT00439894 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2008-03-21

No results posted yet for this study

Summary

Ancillary study to the Etanercept protocol 20060104. Subjects have been asked to provide additional blood samples for further assessment.

Conditions

Interventions

PROCEDURE

Blood draw

blood draw at baseline, week 12 and week 24

Sponsors & Collaborators

Principal Investigators

  • MD · Amgen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2007-08-31
Completion
2007-10-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00439894 on ClinicalTrials.gov